694 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Wednesday’s Close
LLY Eli Lilly and Company $105.71 $113.53B N/A
Article Searches
Pharma Stock Roundup: Mixed 2Q Results from Pfizer, Bristol-Myers Announces IO Deals http://www.zacks.com/stock/news/270774/pharma-stock-roundup-mixed-2q-results-from-pfizer-bristol-myers-announces-io-deals?cid=CS-ZC-FT-270774 Aug 04, 2017 - Pfizer's (PFE) results were mixed while Teva had a dismal quarter with the company missing estimates as well as cutting its outlook and guidance.
Early movers: ADP, WCG, F, NWL, VIAB, PBPB, LLY, GPRO & more https://www.cnbc.com/2017/08/04/early-movers-adp-wcg-f-nwl-viab-pbpb-lly-gpro-more.html Aug 04, 2017 - Names on the move ahead of the open.
3 Biotech Stocks for Enterprising Investors https://www.fool.com/investing/2017/07/29/3-biotech-stocks-for-enterprising-investors.aspx?source=iedfolrf0000001 Jul 29, 2017 - Looking for a few biotech stocks that have upside potential? Here's why our investors think you should check out Edge Therapeutics, Aratana Therapeutics, and Alkermes.
Eli Lilly & Co. (LLY) Q2 2017 Results - Earnings Call Transcript https://seekingalpha.com/article/4090428-eli-lilly-and-co-lly-q2-2017-results-earnings-call-transcript?source=feed_all_articles Jul 25, 2017 - Eli Lilly & Co. (NYSE:LLY)Q2 2017 Earnings CallJuly 25, 2017 9:00 am ETExecutivesDavid A. Ricks - Eli Lilly & Co.Susan Mahony - Eli Lilly & Co.Levi Garraway - Eli Lilly & Co.Derica W. Rice - Eli Lilly
Early movers: MMM, UTX, DD, CAT, GM, LLY, KORS, C, WMT & more https://www.cnbc.com/2017/07/25/early-movers-mmm-utx-dd-cat-gm-lly-kors-c-wmt-more.html Jul 25, 2017 - Names on the move ahead of the open.
Early movers: MMM, UTX, DD, CAT, GM, LLY, KORS, C, WMT & more http://www.cnbc.com/2017/07/25/early-movers-mmm-utx-dd-cat-gm-lly-kors-c-wmt-more.html Jul 25, 2017 - Names on the move ahead of the open.
These 5 Drugs Could Be Worth $45 Billion -- and They're Not Even on the Market Yet https://www.fool.com/investing/2017/07/23/these-5-drugs-could-be-worth-45-billion-and-theyre.aspx?source=iedfolrf0000001 Jul 23, 2017 - Biogen, Johnson & Johnson, Lilly, AbbVie, and Celgene could have huge winners on their hands in the near future.
2 Reasons Incyte Is a Better Growth Stock Than Exelixis -- and 1 Reason It Isn't https://www.fool.com/investing/2017/07/21/2-reasons-incyte-is-a-better-growth-stock-than-exe.aspx?source=iedfolrf0000001 Jul 21, 2017 - Which is the better growth stock going forward -- Exelixis or Incyte? It depends.
Can Biogen (BIIB) Keep the Earnings Streak Alive in Q2? http://www.zacks.com/stock/news/268102/can-biogen-biib-keep-the-earnings-streak-alive-in-q2?cid=CS-ZC-FT-268102 Jul 19, 2017 - At Biogen's (BIIB) Q2 call, investor focus will remain on Tecfidera's scrip trends, pipeline progress and acquisition plans. All eyes will also be on Spinraza's performance in Q2.
Here's Why Alder Biopharmaceuticals Inc Stock Is Bouncing Back https://www.fool.com/investing/2017/07/13/heres-why-alder-biopharmaceuticals-inc-is-bouncing.aspx?source=iedfolrf0000001 Jul 13, 2017 - Shares popped after the company released the pricing details of its recently announced stock offering.

Pages: 1...5253545556575859606162...70

<<<Page 57>